DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Mundipharma acquires biosimilars development company
The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...
BioIVT acquires CTLS a UK blood donor facility
BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...
Tusk Therapeutics to be acquired by Roche
Tusk Therapeutics Ltd has been acquired by Roche. Tusk was founded in 2014 by Droia Oncology Ventures, Tusk’s majority shareholder. Under the terms of...
PharmaDoctor and Star enter into a strategic partnership
PharmaDoctor (owned by Escripts Marketing Ltd), and Star (part of the Uniphar Group), are pleased to announce a strategic partnership between the two companies...
Novo Nordisk acquires Ziylo to accelerate glucose responsive insulin
Ziylo and Novo Nordisk have announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based...
Syneos Health acquires advisory & operational solutions provider Kinapse
Syneos Health, Inc. a biopharmaceutical solutions organisation, has announced the acquisition of Kinapse, a market leading advisory and operational solutions provider to the global...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...